MAIT cell activation augments adenovirus vector vaccine immunogenicity
Mucosal-associated invariant T (MAIT) cells are innate sensors of viruses and can augment
early immune responses and contribute to protection. We hypothesized that MAIT cells may …
early immune responses and contribute to protection. We hypothesized that MAIT cells may …
MAIT cells in health and disease
NM Provine, P Klenerman - Annual review of immunology, 2020 - annualreviews.org
Mucosal-associated invariant T (MAIT) cells have been attracting increasing attention over
the last few years as a potent unconventional T cell subset. Three factors largely account for …
the last few years as a potent unconventional T cell subset. Three factors largely account for …
[HTML][HTML] Identification of immune correlates of fatal outcomes in critically ill COVID-19 patients
J Youngs, NM Provine, N Lim, HR Sharpe… - PLoS …, 2021 - journals.plos.org
Prior studies have demonstrated that immunologic dysfunction underpins severe illness in
COVID-19 patients, but have lacked an in-depth analysis of the immunologic drivers of death …
COVID-19 patients, but have lacked an in-depth analysis of the immunologic drivers of death …
[HTML][HTML] Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report
…, CN Fhogartaigh, L Meredith, NM Provine… - Nature …, 2020 - nature.com
The response to the coronavirus disease 2019 (COVID-19) pandemic has been hampered
by lack of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
by lack of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
[HTML][HTML] Unique and Common Features of Innate-Like Human Vδ2+ γδT Cells and Mucosal-Associated Invariant T Cells
NM Provine, B Binder, MEB FitzPatrick… - Frontiers in …, 2018 - frontiersin.org
Mucosal-associated invariant T (MAIT) cells are innate-like T cells abundant in humans that
can be activated in a TCR-independent manner by inflammatory and antiviral cytokines. In …
can be activated in a TCR-independent manner by inflammatory and antiviral cytokines. In …
[HTML][HTML] T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
…, D Wright, D Bellamy, M Bittaye, C Dold, NM Provine… - Nature medicine, 2021 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
Coronavirus Disease 2019 (COVID-19), has caused a global pandemic, and safe, effective …
Coronavirus Disease 2019 (COVID-19), has caused a global pandemic, and safe, effective …
[HTML][HTML] Single-cell analysis of human MAIT cell transcriptional, functional and clonal diversity
…, GF Hess, M Filipowicz Sinnreich, NM Provine… - Nature …, 2023 - nature.com
Mucosal-associated invariant T (MAIT) cells are innate-like T cells that recognize microbial
metabolites through a semi-invariant T cell receptor (TCR). Major questions remain regarding …
metabolites through a semi-invariant T cell receptor (TCR). Major questions remain regarding …
[PDF][PDF] Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
Extension of the interval between vaccine doses for the BNT162b2 mRNA vaccine was
introduced in the United Kingdom to accelerate population coverage with a single dose. At this …
introduced in the United Kingdom to accelerate population coverage with a single dose. At this …
Vaccine-elicited CD4 T cells induce immunopathology after chronic LCMV infection
CD4 T cells promote innate and adaptive immune responses, but how vaccine-elicited CD4
T cells contribute to immune protection remains unclear. We evaluated whether induction of …
T cells contribute to immune protection remains unclear. We evaluated whether induction of …
[HTML][HTML] T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre …
Background Previous infection with SARS-CoV-2 affects the immune response to the first
dose of the SARS-CoV-2 vaccine. We aimed to compare SARS-CoV-2-specific T-cell and …
dose of the SARS-CoV-2 vaccine. We aimed to compare SARS-CoV-2-specific T-cell and …